Format

Send to

Choose Destination
Arch Phys Med Rehabil. 2011 Dec;92(12):1937-43. doi: 10.1016/j.apmr.2011.06.031.

Muscle changes following cycling and/or electrical stimulation in pediatric spinal cord injury.

Author information

1
Department of Physical Therapy, University of the Sciences, Philadelphia, PA 19104, USA. t.johnston@usp.edu

Abstract

OBJECTIVE:

To determine the effect of cycling, electrical stimulation, or both, on thigh muscle volume and stimulated muscle strength in children with spinal cord injury (SCI).

DESIGN:

Randomized controlled trial.

SETTING:

Children's hospital specializing in pediatric SCI.

PARTICIPANTS:

Children (N=30; ages, 5-13y) with chronic SCI.

INTERVENTIONS:

Children were randomly assigned to 1 of 3 interventions: functional electrical stimulation cycling (FESC), passive cycling (PC), and noncycling, electrically stimulated exercise (ES). Each group exercised for 1 hour, 3 times per week for 6 months at home.

MAIN OUTCOME MEASURES:

Preintervention and postintervention, children underwent magnetic resonance imaging to assess muscle volume, and electrically stimulated isometric muscle strength testing with the use of a computerized dynamometer. Data were analyzed via analyses of covariance (ANCOVA) with baseline measures as covariates. Within-group changes were assessed via paired t tests.

RESULTS:

All 30 children completed the training. Muscle volume data were complete for 24 children (8 FESC, 8 PC, 8 ES) and stimulated strength data for 27 children (9 per group). Per ANCOVA, there were differences between groups (P<.05) for quadriceps muscle volume and stimulated strength, with the ES group having greater changes in volume and the FESC group having greater changes in strength. Within-group analyses showed increased quadriceps volume and strength for the FESC group and increased quadriceps volume for the ES group.

CONCLUSIONS:

Children receiving either electrically stimulated exercise experienced changes in muscle size, stimulated strength, or both. These changes may decrease their risk of cardiovascular disease, insulin resistance, glucose intolerance, and type 2 diabetes.

CLINICAL TRIALS REGISTRATION NUMBER:

NCT00245726.

PMID:
22133240
DOI:
10.1016/j.apmr.2011.06.031
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center